Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 167-180

  Gomez, Christopher M ^a,b   Maselli, Ricardo ^c   Williams, Joan M ^a   Bhattacharyya, Bula B ^d   Wollmann, Robert L ^e   Day, John W ^a  

^a Department of Neurology ^*  (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; GENETIC MANIPULATION; MOUSE; MUSCLE ACTION POTENTIAL; MUSCLE FATIGUE; MUSCLE WEAKNESS; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PATCH CLAMP; POINT MUTATION; RECEPTOR DOWN REGULATION; TRANSGENE; VOLTAGE CLAMP;

ANIMALIA;

EID: 0031904123     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10923.x     Document Type: Conference Paper

References (29)

1. ENGEL, A. G., E. H. LAMBERT, D. M. MULDER et al. 1982. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann. Neurol. 11(6): 553-569.
2. OOSTERHUIS, H. J., J. NEWSOM-DAVIS, J. H. WOKKE et al. 1987. The slow channel syndrome: two new cases. Brain 110: 1061-1079.
3. ENGEL, A. G. 1994. Myasthenic syndromes. In Myology. Second edition. Vol. 2, p. 1798-1835. McGraw-Hill. New York.
4. OHNO, K., D. HUTCHINSON, M. MILONE et al. 1995. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the e subunit. Proc. Natl. Acad. Sci. U.S.A. 92: 758-762.
5. GOMEZ, C. M. & J. T. GAMMACK. 1995. A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Neurology 45(5): 982-985.
6. GOMEZ, C. M., R. MASELLI, J. LASALDE et al. 1996. A β subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome. Ann. Neurol. 39(6): 717-723.
7. OHNO, K., M. MILONE, H-L. WANG et al. 1996. Identification of neuromuscular junction acetylcholine receptor mutations in the slow-channel congenital myasthenic syndrome. Neurology 46: A214.
8. ENGEL, A. G., K. OHNO, M. MILONE et al. 1996. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum. Mol. Genet. 5(9): 1217-1227.
9. MILONE, M., H-L. WANG, K. OHNO et al. 1997. Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the m2 domain of the acetylcholine receptor alpha subunit. J. Neurosci. 17(15): 5651-5665.
10. (a) CROXEN, R., C. NEWLAND, D. BEESON et al. 1997. Mutations in different functional domains of the human muscle acetylcholine receptor a subunit in patients with the slow-channel congenital myasthenic syndrome. Hum. Mol. Genet. 6(5): 767-774;
11. (b) SINE, S. M., K. OHNO, C. BOUZAT et al. 1995. Mutation of the acetylcholine receptor a subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 15: 229-239.
12. GOMEZ, C. M., S. TAMAMIZU, J. LASALDE et al. 1996. In vitro and in vivo properties of an acetylcholine receptor (AChR) mutation in a family with the slow-channel syndrome (SCS). Neurology 46(2): A310.
13. GOMEZ, C. M., R. MASELLI, J. E. GUNDECK et al. 1997. Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction. J. Neurosci. 17(11): 4170-4179.
14. GOMEZ, C. M., B. B. BHATTACHARYYA, P. CHARNET et al. 1996. A transgenic mouse model of the slow-channel syndrome. Muscle Nerve 19: 79-87.
15. JOHNSON, J. E., B. J. WOLD & S. D. HAUSCHKA. 1989. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol. Cell. Biol. 9(8): 3393-3399.
16. HOGAN, R., F. COSTANTINI & E. LACET. 1986. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory. Cold Spring Harbor, New York.
17. SAIKI, R. K., D. H. GELFAND, S. STOFFEL et al. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239(4839): 487-491.
18. GARDNER, P. D. 1990. Nucleotide sequence of the epsilon-subunit of the mouse muscle nicotinic acetylcholine receptor. Nucleic Acids Res. 18(22): 100.
19. GORMAN, C. M., L. F. MOFFAT & B. H. HOWARD. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044-1051.
20. DIONNE, V E. & C. F. STEVENS. 1975. Voltage dependence of agonist effectiveness at the frog neuromuscular junction: resolution of a paradox. J. Physiol. 251: 245-270.
21. GLAMINOVIC, M. I. 1979. Voltage clamping of unparalysed cut diaphragm for the study of transmitter release. J. Physiol. 290: 467-480.
22. BHATTACHARYYA, B. B., J. DAY, J. E. GUNDECK, S. LEONARD, R. WOLLMANN & C. GOMEZ. 1997. Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of synaptic currents. Synapse 27(4): 367-377.
23. DEMPSTER, J. 1993. Computer Analysis of Electrophysiological Signals. Harcourt Brace Jovanovich/Academic Press. New York.
24. PESTRONK, A., D. B. DRACHMAN & S. G. SELF. 1985. Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates. Muscle Nerve 8(3): 245-251.
25. MAGLEDY, K. L. & B. S. PALLOTTA. 1981. A study of desensitization of acetylcholine receptors using nerve-released transmitter in the frog. J. Physiol. 316: 225-250.
26. OHNO, K., P. A. QUIRAM, M. MILONE et al. 1997. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene-identification and functional characterization of six new mutations. Hum. Mol. Genet. 6(5): 753-766.
27. WANG, H-L., A. AUERBACH, N. BREN, K. OHNO, A. G. ENGEL & S. M. SINE. 1997. Mutation in the ml domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J. Gen. Physiol. 109(6): 757-766.
28. WALKE, W., J. STAPLE, L. ADAMS, M. GNEGY, K. CHAHINE & D. GOLDMAN. 1994. Calcium-dependent regulation of rat and chick muscle nicotinic acetylcholine receptor (nAChR) gene expression. J. Biol. Chem. 269(30): 19447-19456.
29. LAMBERT, E. H., J. M. LINDSTROM & V. A. LENNON. 1976. End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann. N.Y. Acad. Sci. 274: 300-318.